Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Cardiology
•
Interventional Cardiology
What techniques do you use in the lab to reduce the amount of contrast that needs to be used in patients with CKD?
Answer from: at Academic Institution
Avoid LV angiogram. Use ECHO instead to assess LV function.
Sign In
or
Register
to read more
Answer from: at Academic Institution
Reducing Fr size Limited views Using co-registration tools Occasional addition of an NS mix
Comments
at Cardiology Associates Of Fairfield County
Using IVUS can also be helpful instead of taking m...
at Johns Hopkins University
Here's a summary! assist injection device cons...
12387
12413
Sign In
or
Register
to read more
24167
23057
Related Questions
In patients with post-MI LV thrombus which resolves after 3-6 months of anticoagulation, would you consider surveillance imaging for thrombus recurrence if there is persistent apical akinesis?
Is there any difference between colchicine 0.5mg vs 0.6 mg for high risk coronary artery disease?
How do you manage anticoagulation/antiplatelet therapies with strong indications for uninterrupted therapy in setting of urgent procedures?
What type of DES should you opt for if a patient has or is concerned about possible nickel allergy?
What are the best techniques to reduce POCUS artifact and increase the diagnostic accuracy of lung ultrasound?
Do you take any special considerations when working up a pregnant patient for secondary causes of hypertension?
When is a reasonable amount of time for patients to be on 90 mg BID of ticagrelor before transitioning to 60 mg BID following PCI?
What techniques do you find most helpful to optimize image acquisition for cardiac POCUS in patients with poor acoustic windows?
Would it be reasonable to begin considering GLP1 RAs or finerenone for patients with heart failure with recovered LVEF in light of recent trials such as SELECT and FINEARTS-HF showing some success in HFpEF and HFmrEF populations?
If a patient has potential arrhythmic-sounding syncope and a noninducible type 2 or 3 Brugada ECG pattern, have we excluded Brugada syndrome as the etiology for their syncope?